Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Milind Nadkar

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
International Journal of Rheumatology|November 12, 2014
Clinical and autoimmune profile of scleroderma patients from Western IndiaVandana Pradhan, Anjali Rajadhyaksha, Milind Nadkar, et al.
The Journal of the Association of Physicians of India|July 14, 2023
Clinical Practice Guidelines for Management of Pain, Agitation, Delirium, Immobility, and Sleep Disturbance in the Intensive Care Unit: The ABCDEF BundleRakesh Bhadade, Minal Harde, Milind Nadkar, et al.
International Journal of Immunogenetics|February 16, 2026
Elucidating the Role of Vitamin D Receptor (VDR) Polymorphisms in Genetic Susceptibility to Systemic Lupus Erythematosus: A Case-Control Study From Western IndiaSwapnal Pawaskar, Durga Chougule, Amrutha Jose, et al.
Cytokine|August 12, 2018
Adipokine interactions promote the pathogenesis of systemic lupus erythematosusDurga Chougule, Milind Nadkar, Krishnamurthy Venkataraman, et al.
Expert Opinion on Biological Therapy|April 9, 2021
A two-arm, randomized, controlled, multi-centric, open-label phase-2 study to evaluate the efficacy and safety of Itolizumab in moderate to severe ARDS patients due to COVID-19Suresh Kumar, Rosemarie De Souza, Milind Nadkar, et al.
Journal of Medical Virology|July 23, 2017
Association of clinical and serological parameters of systemic lupus erythematosus patients with Epstein-Barr virus antibody profileDurga Chougule, Milind Nadkar, Anjali Rajadhyaksha, et al.
Cytokine|April 3, 2023
A comparative study of modulatory interaction between cytokines and apoptotic proteins among Scleroderma patients with and without pulmonary involvementPrasad Khadilkar, Durga Chougule, Tanaya Tipnis, et al.
Scientific Reports|October 31, 2025
Lectin pathway components and autoantibodies as novel immunological biomarkers in systemic lupus erythematosus (SLE) patients from Western IndiaKirti Rai, Ridi Khatri, Amrutha Jose, et al.
Frontiers in Medicine|June 19, 2026
Spectrum of autoantibodies and other serological parameters in connective tissue disease-associated interstitial lung disease patientsPooja Jaiswal, Tanya Athavale, Amita Athavale, et al.
International Journal of Rheumatic Diseases|July 27, 2016
Efficacy and safety of golimumab in Indian patients with rheumatoid arthritis: Subgroup data from GO-MORE studySarvajeet Pal, Sarath Chandra Mouli Veeravalli, Siddharth Kumar Das, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
International Journal of Rheumatology|November 12, 2014
Clinical and autoimmune profile of scleroderma patients from Western IndiaVandana Pradhan, Anjali Rajadhyaksha, Milind Nadkar, et al.
The Journal of the Association of Physicians of India|July 14, 2023
Clinical Practice Guidelines for Management of Pain, Agitation, Delirium, Immobility, and Sleep Disturbance in the Intensive Care Unit: The ABCDEF BundleRakesh Bhadade, Minal Harde, Milind Nadkar, et al.
International Journal of Immunogenetics|February 16, 2026
Elucidating the Role of Vitamin D Receptor (VDR) Polymorphisms in Genetic Susceptibility to Systemic Lupus Erythematosus: A Case-Control Study From Western IndiaSwapnal Pawaskar, Durga Chougule, Amrutha Jose, et al.
Cytokine|August 12, 2018
Adipokine interactions promote the pathogenesis of systemic lupus erythematosusDurga Chougule, Milind Nadkar, Krishnamurthy Venkataraman, et al.
Expert Opinion on Biological Therapy|April 9, 2021
A two-arm, randomized, controlled, multi-centric, open-label phase-2 study to evaluate the efficacy and safety of Itolizumab in moderate to severe ARDS patients due to COVID-19Suresh Kumar, Rosemarie De Souza, Milind Nadkar, et al.
Journal of Medical Virology|July 23, 2017
Association of clinical and serological parameters of systemic lupus erythematosus patients with Epstein-Barr virus antibody profileDurga Chougule, Milind Nadkar, Anjali Rajadhyaksha, et al.
Cytokine|April 3, 2023
A comparative study of modulatory interaction between cytokines and apoptotic proteins among Scleroderma patients with and without pulmonary involvementPrasad Khadilkar, Durga Chougule, Tanaya Tipnis, et al.
Scientific Reports|October 31, 2025
Lectin pathway components and autoantibodies as novel immunological biomarkers in systemic lupus erythematosus (SLE) patients from Western IndiaKirti Rai, Ridi Khatri, Amrutha Jose, et al.
Frontiers in Medicine|June 19, 2026
Spectrum of autoantibodies and other serological parameters in connective tissue disease-associated interstitial lung disease patientsPooja Jaiswal, Tanya Athavale, Amita Athavale, et al.
International Journal of Rheumatic Diseases|July 27, 2016
Efficacy and safety of golimumab in Indian patients with rheumatoid arthritis: Subgroup data from GO-MORE studySarvajeet Pal, Sarath Chandra Mouli Veeravalli, Siddharth Kumar Das, et al.
Pageof 3